ClinicalTrials.Veeva

Menu

Contribution of a Video Support to Inform the Patient Before a Complementary Examination in Infectious Diseases (AVIEMI)

A

Assistance Publique - Hôpitaux de Paris

Status

Completed

Conditions

Infectious Disease

Treatments

Other: Video information
Other: Oral and written information

Study type

Observational

Funder types

Other

Identifiers

NCT06168448
APHP 230351
2023-A00266-39 (Other Identifier)

Details and patient eligibility

About

The purpose of this study is that a video tool coupled with standardized information can increase the patient's understanding of the information and thus optimize their medical care

Full description

Patients admitted to the Infectious and Tropical Diseases Department (MIT) undergo a large number of complementary examinations. In view of their specificity, justified by the often lengthy diagnostic process, as well as by the complexity and diversity of the pathologies, the site of infection and the patient's background (adolescents and adults, migrant patients, immunocompromised patients, Human Immunodeficiency Virus, primary immunodeficiencies, organ transplants, patients with haemopathies, marrow transplants, among others). As a matter of practice, the doctor informs the patient of the prescribed examinations, explaining their purpose and procedure, and outlining any benefits and risks.

The intention is to introduce a tool that complements the information usually provided, and that can be of high quality to improve the patient's perception of understanding. To this end, investigators hypothesize that a tool in video format, built in collaboration with the experience of various technical platforms, could make the experience of understanding information more complete and more accessible to all patients.

Enrollment

97 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient aged ≥ 18 years

  • French speaking language

  • Hospitalized in the Department of Infectious and Tropical Diseases at Hôpital Necker- Enfants malades

  • Prescription, for the first time in its medical history, of one of the following complementary examinations:

    • Bronchial FibroscopyIRM
    • PICC line insertion
    • PET Scanner
  • No expressed oral opposition

Exclusion criteria

  • Patients with dementia or cognitive impairment
  • Non-French-speaking patient

Caregivers' inclusion Criteria:

  • Caregiver belonging at nurse or doctor's category
  • Caregiver working in the Infectious and Tropical Diseases Department at Necker Hospital
  • No expressed oral opposition
  • Caregivers who are not in contact with patients

Trial design

97 participants in 3 patient groups

Group 1 : Patients with oral and written information
Description:
Group made up of patients hospitalized at that time in the infectious diseases department who met the eligibility criteria set out in the protocol. This group of patients will receive the legal oral and written information concerning the additional examination prescribed, as usually delivered by their doctor.
Treatment:
Other: Oral and written information
Group 2 : Patients with oral and written information + video information
Description:
Group made up of patients hospitalized at that time in the infectious diseases department who met the eligibility criteria set out in the protocol. This group of patients will receive the legal oral and written information concerning the additional examination prescribed, as usually delivered by their physician, and in addition the video tool will be applied to them.
Treatment:
Other: Oral and written information
Other: Video information
Group 3 : Caregivers
Description:
Nurses and physicians working in the infectious and tropical diseases department. This group of caregivers will assess the impact of the intervention on their practice.

Trial contacts and locations

1

Loading...

Central trial contact

Elisabete GOMES PIRES, Nurse; Aminata TRAORE

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems